...
机译:贝伐单抗联合伊立替康治疗复发性低度神经胶质瘤患儿的疗效-儿童脑肿瘤联合研究
Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina;
Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois;
Department of Radiology, Boston Children's Hospital, Boston, Massachusetts;
Department of Pathology, Duke University Medical Center, Durham, North Carolina;
Deportment of Biostatistics, Operations and Biostatistics Center, for the Pediatric Brain Tumor Consortium, Memphis, Tennessee;
Deportment of Biostatistics, Operations and Biostatistics Center, for the Pediatric Brain Tumor Consortium, Memphis, Tennessee;
Department of Neurology, Children's National Medical Center, Washington, DC;
Department of Neurosurgery, University of California at San Francisco, San Francisco, California;
Cancer Center Administration, St. Jude Children's Research Hospital, Memphis, Tennessee;
Department of Radiology, Boston Children's Hospital, Boston, Massachusetts;
Department of Radiology, Boston Children's Hospital, Boston, Massachusetts;
Department of Hematology/Oncology, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania;
Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee;
Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois;
Department of Neurological Surgery, Children's Hospital of Pittsburgh, Children's Hospital Drive, Pittsburgh, Pennsylvania;
Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina;
Deportment of Biostatistics, Operations and Biostatistics Center, for the Pediatric Brain Tumor Consortium, Memphis, Tennessee;
Department of Hematology/Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio;
Department of Radiological Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee;
bevacizumab; CPT-11; children; gliomas; recurrent;
机译:贝伐单抗加伊立替康对复发性恶性神经胶质瘤和弥漫性脑干神经胶质瘤的儿童缺乏疗效:一项儿科脑肿瘤研究。
机译:贝伐单抗+伊立替康在小儿复发性室管膜瘤病例中缺乏疗效-小儿脑肿瘤联合体研究
机译:贝伐单抗(BVZ)引起的中枢神经系统肿瘤反复发作的儿童接受BVZ和伊立替康(CPT-11)治疗的毒性:儿科脑肿瘤联合研究(PBTC-022)
机译:预测贝伐单抗治疗的脑肿瘤的可重复性研究
机译:长春新碱,伊非替康,替莫唑胺和贝伐单抗(VIT-B)逐步剂量在患有非造血源性复发或难治性实体瘤的儿童和青少年患者中的I期研究
机译:贝伐单抗联合伊立替康治疗儿童复发性低度神经胶质瘤的疗效-儿童脑肿瘤联合会的一项研究
机译:Bevacizumab Plus Irinotecan在患有复发性低级胶质瘤儿童的疗效 - 儿科脑肿瘤联盟研究